(Start of Back Button) insnapshot (End of Back Button)

Morningstar® Fund Report™

Overview

Chart

Performance

Risk and Rating

Portfolio

Management

Fees

Filings

Print

PDF

Methodology

Glossary

Nippon India Pharma Fund - Growth

Morningstar Rating™ (Relative to Category)	-
Morningstar Return Morningstar Risk (Rel to Cat) Morningstar Rating™ 3-Year - - Not Rated 5-Year - - Not Rated 10-Year - - Not Rated Overall - - Not Rated
Category:  Sector - Healthcare	Click here to see our Methodology

Volatility Measurements	30/04/2024
Volatility 14.60 % 3-Yr Mean Return 16.90 %   Sharpe Ratio 0.71

Modern Portfolio Statistics		-
	Standard Index	Best Fit Index
	S&P BSE Healthcare PR
R-Squared	97.38	-
3-Yr Beta	0.95	-
3-Yr Alpha	1.40	-

Return/Risk Analysis			30/04/2024
Risk Measurement	1 Year	3 Years	5 Years
Standard Deviation	14.75	14.60	18.60
Sharpe Ratio	2.45	0.71	0.94
Sortino Ratio	-	-	-
Positive Months	9	23	38
Negative Months	3	13	22
Worst Month	-3.34	-8.67	-8.67